|
Insider Trading: Altus Pharmaceuticals Inc.
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Altus Pharmaceuticals Inc. in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of Altus Pharmaceuticals Inc. since year 2005. Table 2 shows the detailed insider transactions of Altus Pharmaceuticals Inc. since 2005.
The reporting company's ticker symbol is ALTU.
The reporting company's CIK number is 1340744.
The total value of stock buying since 2005 is $0.
The total value of stock sales is $15,299,383.
The total value of stock exercises is $726,180.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at Altus Pharmaceuticals Inc. (ALTU) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Figure 2. Average prices of insider buys, sales, and option exercises at Altus Pharmaceuticals Inc. (ALTU) in the past 24 months. See table 2 for insider transaction details.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for Altus Pharmaceuticals Inc. (ALTU).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2007-12 | 0 | 0 | 2,300 | 23,319 | 34,300 | 134,456 |
| 2007-11 | 0 | 0 | 2,300 | 27,275 | 2,300 | 9,016 |
| 2007-10 | 0 | 0 | 2,300 | 25,908 | 2,300 | 9,016 |
| 2007-09 | 0 | 0 | 2,300 | 23,696 | 2,300 | 9,016 |
| 2007-08 | 0 | 0 | 12,750 | 130,922 | 12,750 | 49,980 |
| 2007-07 | 0 | 0 | 31,900 | 368,775 | 21,000 | 82,320 |
| 2007-04 | 0 | 0 | 14,875 | 223,089 | 11,750 | 46,060 |
| 2007-03 | 0 | 0 | 22,925 | 351,596 | 13,550 | 53,116 |
| 2007-02 | 0 | 0 | 24,250 | 436,601 | 11,750 | 46,060 |
| 2007-01 | 0 | 0 | 26,250 | 498,671 | 13,750 | 53,900 |
| 2006-12 | 0 | 0 | 37,750 | 723,971 | 33,250 | 130,340 |
| 2006-11 | 0 | 0 | 47,100 | 788,105 | 26,250 | 102,900 |
| 2006-07 | 0 | 0 | 817,749 | 11,677,455 | 0 | 0 |
Table 2. Detailed insider stock purchases, sales, and option exercises
for Altus Pharmaceuticals Inc. (ALTU)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2007-12-17 | Lieber Jonathan I (VP, CFO and Treasurer) | Sale | 1,800 | 10.03 | 18,054 |
| 2007-12-17 | Lieber Jonathan I (VP, CFO and Treasurer) | Option Exercise | 1,800 | 3.92 | 7,056 |
| 2007-12-13 | Berkle Sheldon (President and CEO) | Option Exercise | 32,000 | 3.92 | 125,440 |
| 2007-12-03 | Gallotto Robert (VP, Strategic Planning) | Sale | 500 | 10.53 | 5,265 |
| 2007-12-03 | Gallotto Robert (VP, Strategic Planning) | Option Exercise | 500 | 3.92 | 1,960 |
| 2007-11-15 | Lieber Jonathan I (VP, CFO and Treasurer) | Sale | 1,800 | 11.35 | 20,430 |
| 2007-11-15 | Lieber Jonathan I (VP, CFO and Treasurer) | Option Exercise | 1,800 | 3.92 | 7,056 |
| 2007-11-01 | Gallotto Robert (VP, Strategic Planning) | Sale | 500 | 13.69 | 6,845 |
| 2007-11-01 | Gallotto Robert (VP, Strategic Planning) | Option Exercise | 500 | 3.92 | 1,960 |
| 2007-10-15 | Lieber Jonathan I (VP, CFO and Treasurer) | Sale | 1,800 | 11.46 | 20,628 |
| 2007-10-15 | Lieber Jonathan I (VP, CFO and Treasurer) | Option Exercise | 1,800 | 3.92 | 7,056 |
| 2007-10-01 | Gallotto Robert (VP, Strategic Planning) | Sale | 500 | 10.56 | 5,280 |
| 2007-10-01 | Gallotto Robert (VP, Strategic Planning) | Option Exercise | 500 | 3.92 | 1,960 |
| 2007-09-17 | Lieber Jonathan I (VP, CFO and Treasurer) | Sale | 1,800 | 10.27 | 18,486 |
| 2007-09-17 | Lieber Jonathan I (VP, CFO and Treasurer) | Option Exercise | 1,800 | 3.92 | 7,056 |
| 2007-09-04 | Gallotto Robert (VP, Strategic Planning) | Sale | 500 | 10.42 | 5,210 |
| 2007-09-04 | Gallotto Robert (VP, Strategic Planning) | Option Exercise | 500 | 3.92 | 1,960 |
| 2007-08-15 | Lieber Jonathan I (VP, CFO and Treasurer) | Sale | 9,000 | 10.42 | 93,780 |
| 2007-08-15 | Lieber Jonathan I (VP, CFO and Treasurer) | Option Exercise | 9,000 | 3.92 | 35,280 |
| 2007-08-08 | Gallotto Robert (VP, Strategic Planning) | Sale | 500 | 10.00 | 5,000 |
| 2007-08-08 | Gallotto Robert (VP, Strategic Planning) | Option Exercise | 500 | 3.92 | 1,960 |
| 2007-08-01 | Berkle Sheldon (President and CEO) | Sale | 3,250 | 9.89 | 32,142 |
| 2007-08-01 | Berkle Sheldon (President and CEO) | Option Exercise | 3,250 | 3.92 | 12,740 |
| 2007-07-19 | Berkle Sheldon (President and CEO) | Sale | 8,000 | 11.54 | 92,320 |
| 2007-07-19 | Berkle Sheldon (President and CEO) | Option Exercise | 8,000 | 3.92 | 31,360 |
| 2007-07-18 | Gallotto Robert (VP, Strategic Planning) | Sale | 1,500 | 11.90 | 17,850 |
| 2007-07-18 | Gallotto Robert (VP, Strategic Planning) | Option Exercise | 1,500 | 3.92 | 5,880 |
| 2007-07-18 | Margolin Alexey L (Chief Scientific Officer) | Sale | 10,900 | 11.55 | 125,895 |
| 2007-07-18 | Berkle Sheldon (President and CEO) | Sale | 11,500 | 11.54 | 132,710 |
| 2007-07-18 | Berkle Sheldon (President and CEO) | Option Exercise | 11,500 | 3.92 | 45,080 |
| 2007-04-02 | Gallotto Robert (VP, Strategic Planning) | Sale | 2,000 | 14.93 | 29,860 |
| 2007-04-02 | Gallotto Robert (VP, Strategic Planning) | Option Exercise | 2,000 | 3.92 | 7,840 |
| 2007-04-02 | Margolin Alexey L (Chief Scientific Officer) | Sale | 3,125 | 14.94 | 46,687 |
| 2007-04-02 | Berkle Sheldon (President and CEO) | Sale | 9,750 | 15.03 | 146,542 |
| 2007-04-02 | Berkle Sheldon (President and CEO) | Option Exercise | 9,750 | 3.92 | 38,220 |
| 2007-03-22 | Margolin Alexey L (Chief Scientific Officer) | Sale | 3,125 | 16.00 | 50,000 |
| 2007-03-19 | Margolin Alexey L (Chief Scientific Officer) | Sale | 3,125 | 14.88 | 46,500 |
| 2007-03-15 | Lieber Jonathan I (VP, CFO and Treasurer) | Sale | 1,800 | 14.23 | 25,614 |
| 2007-03-15 | Lieber Jonathan I (VP, CFO and Treasurer) | Option Exercise | 1,800 | 3.92 | 7,056 |
| 2007-03-05 | Margolin Alexey L (Chief Scientific Officer) | Sale | 3,125 | 14.19 | 44,343 |
| 2007-03-01 | Gallotto Robert (VP, Strategic Planning) | Sale | 2,000 | 16.13 | 32,259 |
| 2007-03-01 | Gallotto Robert (VP, Strategic Planning) | Option Exercise | 2,000 | 3.92 | 7,840 |
| 2007-03-01 | Berkle Sheldon (President and CEO) | Sale | 9,750 | 15.68 | 152,880 |
| 2007-03-01 | Berkle Sheldon (President and CEO) | Option Exercise | 9,750 | 3.92 | 38,220 |
| 2007-02-21 | Margolin Alexey L (Chief Scientific Officer) | Sale | 600 | 17.29 | 10,374 |
| 2007-02-20 | Margolin Alexey L (Chief Scientific Officer) | Sale | 5,650 | 17.37 | 98,140 |
| 2007-02-05 | Margolin Alexey L (Chief Scientific Officer) | Sale | 6,250 | 18.12 | 113,250 |
| 2007-02-01 | Gallotto Robert (VP, Strategic Planning) | Sale | 2,000 | 18.45 | 36,900 |
| 2007-02-01 | Gallotto Robert (VP, Strategic Planning) | Option Exercise | 2,000 | 3.92 | 7,840 |
| 2007-02-01 | Berkle Sheldon (President and CEO) | Sale | 9,750 | 18.25 | 177,937 |
| 2007-02-01 | Berkle Sheldon (President and CEO) | Option Exercise | 9,750 | 3.92 | 38,220 |
| 2007-01-22 | Margolin Alexey L (Chief Scientific Officer) | Sale | 6,250 | 18.73 | 117,062 |
| 2007-01-16 | Lieber Jonathan I (VP, CFO and Treasurer) | Sale | 2,000 | 19.24 | 38,480 |
| 2007-01-16 | Lieber Jonathan I (VP, CFO and Treasurer) | Option Exercise | 2,000 | 3.92 | 7,840 |
| 2007-01-08 | Margolin Alexey L (Chief Scientific Officer) | Sale | 6,250 | 19.40 | 121,249 |
| 2007-01-03 | Gallotto Robert (VP, Strategic Planning) | Sale | 2,000 | 18.90 | 37,800 |
| 2007-01-03 | Gallotto Robert (VP, Strategic Planning) | Option Exercise | 2,000 | 3.92 | 7,840 |
| 2007-01-03 | Berkle Sheldon (President and CEO) | Sale | 9,750 | 18.88 | 184,080 |
| 2007-01-03 | Berkle Sheldon (President and CEO) | Option Exercise | 9,750 | 3.92 | 38,220 |
| 2006-12-27 | Margolin Alexey L (Chief Scientific Officer) | Sale | 6,250 | 19.77 | 123,562 |
| 2006-12-22 | Berkle Sheldon (President and CEO) | Option Exercise | 8,000 | 3.92 | 31,360 |
| 2006-12-20 | Gallotto Robert (VP, Strategic Planning) | Sale | 7,000 | 20.00 | 140,000 |
| 2006-12-20 | Gallotto Robert (VP, Strategic Planning) | Option Exercise | 7,000 | 3.92 | 27,440 |
| 2006-12-20 | Berkle Sheldon (President and CEO) | Sale | 6,500 | 20.07 | 130,455 |
| 2006-12-20 | Berkle Sheldon (President and CEO) | Option Exercise | 6,500 | 3.92 | 25,480 |
| 2006-12-11 | Margolin Alexey L (Chief Scientific Officer) | Sale | 6,250 | 19.21 | 120,062 |
| 2006-12-01 | Gallotto Robert (VP, Strategic Planning) | Sale | 2,000 | 17.83 | 35,660 |
| 2006-12-01 | Gallotto Robert (VP, Strategic Planning) | Option Exercise | 2,000 | 3.92 | 7,840 |
| 2006-12-01 | Berkle Sheldon (President and CEO) | Sale | 9,750 | 17.87 | 174,232 |
| 2006-12-01 | Berkle Sheldon (President and CEO) | Option Exercise | 9,750 | 3.92 | 38,220 |
| 2006-11-27 | Margolin Alexey L (Chief Scientific Officer) | Sale | 6,250 | 18.01 | 112,562 |
| 2006-11-15 | Lieber Jonathan I (VP, CFO and Treasurer) | Sale | 2,000 | 18.61 | 37,220 |
| 2006-11-15 | Lieber Jonathan I (VP, CFO and Treasurer) | Option Exercise | 2,000 | 3.92 | 7,840 |
| 2006-11-13 | Margolin Alexey L (Chief Scientific Officer) | Sale | 7,850 | 16.80 | 132,614 |
| 2006-11-01 | Gallotto Robert (VP, Strategic Planning) | Sale | 14,500 | 16.19 | 234,755 |
| 2006-11-01 | Gallotto Robert (VP, Strategic Planning) | Option Exercise | 14,500 | 3.92 | 56,840 |
| 2006-11-01 | Berkle Sheldon (President and CEO) | Sale | 9,750 | 16.07 | 156,682 |
| 2006-11-01 | Berkle Sheldon (President and CEO) | Option Exercise | 9,750 | 3.92 | 38,220 |
| 2006-07-31 | Vertex Pharmaceuticals Inc / Ma (10% Owner) | Sale | 817,749 | 14.28 | 11,677,455 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Altus Pharmaceuticals Inc. (symbol ALTU,
CIK number 1340744) see
the Securities and Exchange Commission (SEC) website.
|
|
